| Literature DB >> 35045595 |
Cody Goedderz1, Mark A Plantz1, Erik B Gerlach1, Nicholas C Arpey1, Peter R Swiatek1, Colin K Cantrell1, Michael A Terry1, Vehniah K Tjong1.
Abstract
BACKGROUND: Distal biceps rupture is a relatively uncommon injury that can significantly affect quality of life. Early complications following biceps tendon repair are not well described in the literature. This study utilizes a national surgical database to determine the incidence of and predictors for short-term complications following distal biceps tendon repair.Entities:
Keywords: Distal biceps tendon repair; NSQIP; Orthopedic procedures; Risk factors; Postoperative complications
Year: 2022 PMID: 35045595 PMCID: PMC8907497 DOI: 10.5397/cise.2021.00472
Source DB: PubMed Journal: Clin Shoulder Elb ISSN: 1226-9344
Demographics and comorbidities of included patients
| Variable | No. of patients (%) |
|---|---|
| Sex | |
| Male | 2,123 (97.9) |
| Female | 46 (2.1) |
| Age (yr) | |
| 18–29 | 77 (3.6) |
| 30–39 | 391 (18.0) |
| 40–49 | 796 (36.7) |
| 50–59 | 617 (28.4) |
| ≥60 | 288 (13.3) |
| BMI (kg/m2) | |
| Underweight (<18.5) | 80 (3.7) |
| Normal (18.5–24.9) | 163 (7.5) |
| Overweight (25.0–29.9) | 806 (37.2) |
| Obese class I (30.0–34.9) | 705 (32.5) |
| Obese class II (35.0–39.9) | 257 (11.8) |
| Obese class III (≥40.0) | 158 (7.3) |
| Comorbidity | |
| Diabetes | 123 (5.7) |
| Smoking | 322 (14.8) |
| COPD | 20 (0.9) |
| Congestive heart failure | 1 (0.05) |
| Hypertension | 542 (25.0) |
| Dialysis | 1 (0.05) |
| Chronic steroid use | 30 (1.4) |
| Bleeding disorder | 20 (0.9) |
| ASA class | |
| Class 1 (no disturbance) | 629 (29.0) |
| Class 2 (mild disturbance) | 1,216 (56.1) |
| Class 3 (severe disturbance) | 316 (14.6) |
| Class 4+ (life threatening) | 5 (0.2) |
| Functional status | |
| Independent | 2,158 (99.5) |
| Partially dependent | 2 (0.1) |
| Totally dependent | 0 |
BMI: body mass index, COPD: chronic obstructive pulmonary disease, ASA: American Society of Anesthesiologists.
Surgical and hospital course of included patients
| Variable | No. of patients (%) |
|---|---|
| Anesthesia | |
| Epidural | 2 (0.1) |
| General | 1,984 (91.5) |
| MAC/IV sedation | 98 (4.5) |
| Regional | 81 (3.7) |
| Spinal | 2 (0.1) |
| Other | 2 (0.1) |
| Operative time (min) | |
| <60 | 670 (30.9) |
| 60–120 | 1,259 (58.0) |
| >120 | 227 (10.5) |
| Disposition | |
| Inpatient | 135 (6.2) |
| Outpatient | 2,034 (93.8) |
MAC/IV, monitored anesthesia care.
30-day general, surgical, and medical measures/complications following procedure
| 30-Day outcome measure | No. of patients (%) |
|---|---|
| Readmission | 15 (0.7) |
| Reoperation | 12 (0.6) |
| Non-home discharge | 21 (1.0) |
| Mortality | 1 (<0.1) |
| Surgical complications | |
| Overall | 11 (0.5) |
| Superficial surgical site infection | 5 (0.2) |
| Wound infection | 2 (0.1) |
| Deep surgical site infection | 2 (0.1) |
| Dehiscence | 2 (0.1) |
| Bleeding | 1 (<0.1) |
| Medical complication | |
| Overall | 6 (0.3) |
| Pneumonia | 1 (0.05) |
| Pulmonary embolism | 1 (0.05) |
| Urinary tract infection | 4 (0.2) |
| Cardiac arrest | 1 (0.05) |
| Myocardial infarction | 0 |
| Systemic sepsis | 1 (0.05) |
Statistically significant risk factors identified for corresponding 30-day outcome measures/complications
| 30-Day outcome measure | Risk ratio (95% CI) |
|---|---|
| Readmission | Diabetes: 4.238 (1.180–15.218) |
| Reoperation | - |
| Non-home discharge | ≥60 yr: 4.150 (1.611–10.686) |
| Smoking: 3.006 (1.123–8.044) | |
| Mortality | - |
| Surgical complication | Obese class II: 4.120 (1.123–15.120) |
| Independent functional status: 0.023 (0.002–0.221) | |
| COPD: 21.981 (3.719–129.924) | |
| Inpatient surgery: 8.606 (2.266–32.689) | |
| Medical complication | Male: 0.024 (0.005–0.126) |
CI: confidence interval, COPD: chronic obstructive pulmonary disease.